Shares of AbbVie Inc. ABBV, -0.44% slipped 0.44% to $134.98 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +0.74% rising 0.74% to 4,472.16 and the Dow Jones Industrial Average DJIA, +0.25% rising 0.25% to 34,347.43.
AbbVie Inc. closed $33.13 short of its 52-week high ($168.11), which the company achieved on January 6th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson JNJ, -0.35% fell 0.35% to $158.08 and Pfizer Inc. PFE, -0.08% fell 0.08% to $35.99.
Trading volume (4.8 M) remained 1.2 million below its 50-day average volume of 5.9 M.